C-Fms-IN-7
C-Fms-IN-7 is a cFMS inhibitor extracted from patent WO2011079076A1, example159, has an IC50 of 18.5 nM[1].
Product Specifications
CAS Number
[1313408-89-7]
UNSPSC
12352005
Target
C-Fms
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/c-fms-in-7.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CN=C2C=C(SC)C=CN21)NC3=CC=CC4=C3C(C5CC5)=NN4CC6=NC(C)=CC=C6
Molecular Formula
C26H24N6OS
Molecular Weight
468.57
References & Citations
[1]Mark Laurence Boys, et al. Substituted n- (1h-indazol-4-yl) imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors. WO2011079076A1
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
